QP Release. GSK, as holder of the Regulatory Approvals of the COVID Products, shall be responsible for the certification by a qualified person and release of Manufactured batches of COVID Products in accordance with GMP, that are distributed under such Regulatory Approval (whether for Development or Commercialization purposes), and the Quality Agreements shall reflect the same.
Appears in 4 contracts
Samples: Covid Cla Third Amendment and Restatement Agreement (CureVac N.V.), Covid Cla Amendment and Restatement Agreement (CureVac N.V.), Covid Collaboration and License Agreement
